Free Trial
NASDAQ:ORKA

Oruka Therapeutics 2/1/2024 Earnings Report

Oruka Therapeutics logo
$11.88 +0.41 (+3.54%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Oruka Therapeutics EPS Results

Actual EPS
-$11.52
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Oruka Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Oruka Therapeutics Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Oruka Therapeutics' Q1 2025 earnings is scheduled for Thursday, August 7, 2025

Conference Call Resources

Oruka Therapeutics Earnings Headlines

Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
See More Oruka Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Oruka Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oruka Therapeutics and other key companies, straight to your email.

About Oruka Therapeutics

Oruka Therapeutics (NASDAQ:ORKA) is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

View Oruka Therapeutics Profile

More Earnings Resources from MarketBeat